The medical cannabis wholesale market across Germany and Europe is expanding at a remarkable pace. Since the introduction of the Cannabis Act (CanG) in April 2024 — and the statutory health insurance reimbursement obligations it brought with it — Germany has firmly established itself as Europe’s largest medical cannabis market. Industry analysts place annual market value at between €400 million and €600 million, with a clear trajectory toward €1 billion by 2028.
For pharmacies, importers, and pharmaceutical wholesalers, this raises one critical question: where do you find reliable, quality-certified suppliers capable of consistent delivery while meeting every applicable regulatory requirement?
What Is Medical Cannabis Wholesale — and Who Is Authorised to Trade?
Legal Framework in Germany
Commercial trade in medical cannabis in Germany is subject to stringent regulatory requirements. Any operator wishing to participate in medical cannabis wholesale must hold:
- A wholesale distribution authorisation under § 52a of the German Medicines Act (AMG)
- A narcotics permit under the Narcotics Act (BtMG), as cannabis remains a controlled substance
- Full compliance with Good Distribution Practice (GDP) guidelines
- An import authorisation from BfArM (Federal Institute for Drugs and Medical Devices) for products sourced from third countries
In addition, every imported batch must be released by a Qualified Person (QP) resident in Germany — a requirement that is frequently underestimated but is non-negotiable from a regulatory standpoint.
Who Buys at the Wholesale Level?
The principal buyers in the medical cannabis wholesale supply chain are:
- Pharmacies sourcing prescription cannabis flower or extracts directly from wholesalers
- Pharmaceutical distributors acting as intermediaries between producers and dispensing pharmacies
- Clinics and medical practices holding the appropriate dispensing licences
- Downstream manufacturers requiring active pharmaceutical ingredients (APIs) for cannabis-based medicines
Key Quality Standards at a Glance
EU-GMP — The Quality Benchmark for European Market Access
Any operator seeking to import medical cannabis from a third country into Germany must hold EU Good Manufacturing Practice (GMP) certification. This is the non-negotiable minimum requirement for access to pharmaceutical distribution channels within the European Union.
EU-GMP certification ensures that:
- Manufacturing facilities are designed and operated to pharmaceutical-grade standards
- Full batch documentation and end-to-end traceability are maintained
- Microbiological and chemical quality testing is conducted in accordance with the German Pharmacopoeia (DAB)
- Internal quality management systems are subject to regular audits by European competent authorities
GACP — The Standard at Cultivation Level
At the cultivation stage, Good Agricultural and Collecting Practices (GACP) certification represents the international reference standard. It guarantees that cannabis is grown free from pesticides, heavy metals, and other contaminants — an essential prerequisite for downstream EU-GMP processing.
Thailand as an Emerging Supplier in the Medical Cannabis Wholesale Market
Why Thailand?
While Portugal and Canada have traditionally dominated German import statistics, Thailand is steadily positioning itself as a competitive alternative in the global medical cannabis wholesale landscape. The reasons are compelling:
- Favourable climatic conditions that support high-yield cannabis cultivation
- Significantly lower production costs compared to European producers
- A progressive regulatory environment: Thailand was the first country in Asia to legalise medical cannabis
- Rapidly developing infrastructure for pharmaceutical-grade indoor cultivation
International industry observers confirm that Thailand-based producers with verified EU-GMP compliance and rigorous quality assurance systems are well placed to offer highly competitive products for European markets.
Elephant Cann — EU-GMP Cannabis Supplier from Thailand
Elephant Cann stands out as a prime example of Thailand’s new generation of pharmaceutical-grade cannabis producers. Founded in 2019, the company was among the first in Thailand to pursue systematic research and development in medical cannabis varieties.
Elephant Cann holds GACP certification from SGS for medical cannabis production and operates state-of-the-art hydroponic indoor cultivation systems within a controlled cleanroom environment. Its Bangkok-based facility is built to the highest pharmaceutical quality standards:
- Pesticide-free and chemical-free cultivation throughout
- Full batch traceability at every stage of the supply chain
- High-grade THC and CBD cultivars tailored to specific medical indications
- A consistent, export-oriented approach aligned with international regulatory requirements
For pharmaceutical companies and importers seeking a dependable EU-GMP cannabis supplier, Elephant Cann’s wholesale offering merits serious consideration:
👉 Elephant Cann – EU-GMP Cannabis Supplier (Thailand)
Challenges in Importing Medical Cannabis from Third Countries
The “GMP Washing” Problem
A well-documented phenomenon in the industry is so-called “GMP washing”: product leaves its country of origin with GACP certification, is processed through an EU-based intermediary — typically in the Netherlands, Portugal, or the Czech Republic — and re-enters the supply chain under that intermediary’s EU-GMP designation.
This practice significantly undermines transparency for buyers operating in the medical cannabis wholesale space. Professional importers should therefore insist on tracing the complete supply chain and request direct access to audit records, certificates, and batch analysis reports from the original producer.
Import Authorisation and QP Batch Release
Every batch of medical cannabis imported into Germany requires a formal import authorisation from BfArM as well as batch release by a Qualified Person based in Germany. This two-stage process extends lead times considerably and demands precise forward planning across the supply chain.
Quota Allocation and Supply Security
International demand for EU-GMP-certified medical cannabis regularly outstrips available supply in certain cultivar categories. Experienced wholesalers mitigate this risk by securing annual supply agreements with fixed volumes and price commitments, ensuring both product availability and reliable cost forecasting.
How to Choose the Right Partner in Medical Cannabis Wholesale
Supplier Due Diligence Checklist
When evaluating a supplier for medical cannabis wholesale, the following criteria should be systematically assessed:
- Current EU-GMP certificates — issued by a recognised European competent authority
- GACP certification at cultivation level, ideally verified by an accredited third party such as SGS or Bureau Veritas
- Full Certificates of Analysis (COAs) for every batch, covering pesticide residues, heavy metals, and residual solvents
- References and a proven export track record into EU markets
- A stable supply chain with clearly defined SLAs covering lead times, minimum order quantities, and contingency arrangements
- Transparent pricing structures with no hidden certification surcharges
What Product Forms Are Available at Wholesale?
The professional medical cannabis wholesale market typically offers the following product categories:
- Cannabis flower (dried, hermetically sealed, batch-tested) meeting DAB standards
- Cannabis extracts and oils with defined THC/CBD concentrations
- Dronabinol as an API for compounded and magistral preparations
- Cannabidiol (CBD) as a raw material for pharmaceutical and cosmetic downstream processing
Market Outlook and Growth Trajectory
Key Growth Drivers to 2028
The European medical cannabis wholesale market is underpinned by several structural tailwinds:
- Rising patient numbers in Germany: Since the reclassification under BtMG, the number of GKV-reimbursed patients has surpassed 100,000, with the private prescription cohort adding considerably to that figure
- Expanding therapeutic indications: Medical cannabis is increasingly prescribed for chronic pain, spasticity associated with multiple sclerosis, ADHD, sleep disorders, and a growing range of further conditions
- Regulatory liberalisation across additional EU member states, opening new export markets for compliant producers
- Manufacturing innovation that continues to drive down production costs while enhancing product consistency
Thailand as a Strategic Long-Term Supplier
For German importers and pharmaceutical wholesalers looking to diversify their supply chains, Thailand presents a genuinely compelling opportunity. Producers with verified EU-GMP compliance, demonstrated export experience, and competitive pricing structures — such as Elephant Cann — represent ideal partners for building durable, long-term supply relationships.
Conclusion: Quality and Compliance as the Cornerstones of Medical Cannabis Wholesale
Medical cannabis wholesale is not conventional commodity trading. It demands deep regulatory expertise, a pharmaceutical quality mindset, and robust partner structures across every link in the supply chain.
Operators seeking sustained success — whether as importers, distributors, or dispensing pharmacies — consistently look to suppliers who combine supply chain transparency, EU-GMP certification, and proven GACP cultivation practices. Producers such as Elephant Cann in Thailand demonstrate that high-quality, pharmaceutically compliant cannabis does not have to originate in Europe to compete effectively on the German market.
Learn more: EU-GMP Cannabis Supplier – Elephant Cann Thailand
This article is intended solely as an informational resource for professionals operating within the pharmaceutical and medical sectors. It is not directed at end consumers.